Researchers Database
NAKAMURA FUMI
Affiliation： Department of Hematology and Oncology Position： Senior Assistant Professor | |||
Last Updated :2026/04/21
Research achievements
Published Papers
- PECAM is an effective and safe anthracycline-containing third-line regimen for patients with relapsed or refractory non-Hodgkin lymphoma., Nakamura Fumi;Arai Honoka;Tokita Katsuya;Furuichi Shiho;Sugita-Nagasawa Fusako;Takahashi Wataru;Handa Tomoyuki;Iso Hisako;Tadokoro Jiro;Tsurumi Shigeharu;Nakamura Yuko;Nakamura Yuka;Sasaki Ko;Seo Sachiko;Ichikawa Motoshi;Mitani Kinuko, Leukemia & lymphoma, 62(1), 239-242, 11 Sep. 2020
- Extraosseous plasmacytoma in the nasal cavity after rituximab therapy against pulmonary MALT lymphoma., Fumi Nakamura, Fumihiko Nakamura, Masako Ikemura, Masashi Fukayama, Mineo Kurokawa, Annals of hematology, 95(10), 1733-5, Oct. 2016
- Development of Philadelphia chromosome-negative acute myeloid leukemia with IDH2 and NPM1 mutations in a patient with chronic myeloid leukemia who showed a major molecular response to tyrosine kinase inhibitor therapy., Nakamura Fumi;Arai Honoka;Nannya Yasuhito;Ichikawa Motoshi;Furuichi Shiho;Nagasawa Fusako;Takahashi Wataru;Handa Tomoyuki;Nakamura Yuko;Tanaka Hiroko;Nakamura Yuka;Sasaki Ko;Miyano Satoru;Ogawa Seishi;Mitani Kinuko, International journal of hematology, 05 Jan. 2021
- Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for NK-cell therapy in acute myeloid leukemia., Kaito Yuta;Sugimoto Emi;Nakamura Fumi;Tsukune Yutaka;Sasaki Makoto;Yui Shunsuke;Yamaguchi Hiroki;Goyama Susumu;Nannya Yasuhito;Mitani Kinuko;Tamura Hideto;Imai Yoichi, Haematologica, 21 Sep. 2023
- Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12)., Nakamura Fumi;Seo Sachiko;Nannya Yasuhito;Ayabe Rika;Takahashi Wataru;Handa Tomoyuki;Arai Honoka;Iso Hisako;Nakamura Yuko;Nakamura Yuka;Sasaki Ko;Ichikawa Motoshi;Imai Yoichi;Ogawa Seishi;Mitani Kinuko, International journal of hematology, 118(3), 388-393, 17 Mar. 2023
- Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2 registry databases in Japan., Nakazawa Hideyuki;Sakai Kaoko;Ohta Akiko;Fujishima Naohito;Matsuda Akira;Hosokawa Kohei;Nakamura Fumi;Nakao Shinji;Mitani Kinuko;Ishida Fumihiro, Blood advances, 6(24), 6282-6290, 27 Dec. 2022
- Emergence of t(3;21)(q26.2;q22) during eltrombopag treatment in a patient with relapsed aplastic anemia who received chemotherapy for angioimmunoblastic T-cell lymphoma., Nakamura Fumi;Nakamura Yuka;Nannya Yasuhito;Arai Honoka;Shimbo Kei;Nakamura Yuko;Seo Sachiko;Sasaki Ko;Ichikawa Motoshi;Ogawa Seishi;Mitani Kinuko, Leukemia research reports, 17, 100305, 25 Mar. 2022
- Efficient production of human neutrophils from iPSCs that prevent murine lethal infection with immune cell recruitment., Miyauchi Masashi;Ito Yusuke;Nakahara Fumio;Hino Toshiya;Nakamura Fumi;Iwasaki Yuki;Kawagoshi Taiki;Koya Junji;Yoshimi Akihide;Arai Shunya;Kagoya Yuki;Kurokawa Mineo, Blood, 138(24), 2555-2569, 16 Dec. 2021
- A CML Patient Carrying BCR::ABL1 Splicing Variants Did Not Experience Blast Crisis for 15 Years without Responding to Various TKIs., Nakamura Fumi;Sasaki Ko;Nannya Yasuhito;Iso Hisako;Nakamura Yuko;Imai Yoichi;Ogawa Seishi;Mitani Kinuko, Internal medicine (Tokyo, Japan), 64(3), 455-458, 07 Sep. 2024
- HDAC inhibitors repress Tek and Angpt1 expression and proliferation in RUNX1-MECOM-type leukemia cells., Nakamura Fumi;Nakamura Yuka;Sasaki Ko;Yamazaki Ieharu;Imai Yoichi;Mitani Kinuko, Leukemia research, 156, 107738, 23 Jun. 2025
- Phase II study of the triple combination of rabbit ATG, ciclosporin and eltrombopag in patients with transfusion-dependent aplastic anaemia: West Japan Hematology Study Group (W-JHS) AA02 trial., Nakamura Fumi;Ishiyama Ken;Suzuki Ritsuro;Maruyama Hiroyuki;Onishi Yasushi;Usuki Kensuke;Koh Hideo;Takenaka Katsuto;Saiki Ryunosuke;Ogawa Seishi;Matsumoto Kana;Takahashi Takuto;Hosomichi Kazuyoshi;Zaimoku Yoshitaka;Yoshimura Kenichi;Matsumura Itaru;Akashi Koichi;Nakao Shinji, British journal of haematology, 04 Jan. 2026
Unclear